Showing 361 - 380 results of 417 for search '"lumpectomy"', query time: 0.15s Refine Results
  1. 361

    Postoperative Outcomes following a Multidisciplinary Approach to HIV-positive Breast Cancer Patients by Adaah A. Sayyed, BS, Stephanie Shin, MS, Areeg A. Abu El Hawa, MD, Olutayo Sogunro, DO, Gabriel A. Del Corral, MD, Marc E. Boisvert, MD, MBA, David H. Song, MD, MBA

    Published 2022-09-01
    “…Surgical interventions included lumpectomy (n = 16, 66.7%), simple mastectomy (n = 3, 12.5%), and skin-sparing mastectomy (n = 5. 20.8%). …”
    Get full text
    Article
  2. 362

    Outcomes of reconstructive techniques in breast cancer using BCCT. core software by Sevgi Kurt, Ahmet Serkan İlgün, Enver Özkurt, Gürsel Soybir, Gül Alço, Çağlar Ünal, Filiz Elbüken Çelebi, Tomris Duymaz, Tuğba Kayan Tapan, Naziye Ak, Çetin Ordu, Vahit Özmen

    Published 2024-03-01
    “…Patients were divided into three groups: 1-those who had undergone breast-conserving surgery (245 patients, 71.3%), 2-those who had undergone mini-LDF after lumpectomy (38 patients, 11.02%), and 3- those who underwent reconstruction with implants after nipple-sparing mastectomy (61 patients, 17.68%). …”
    Get full text
    Article
  3. 363

    Rapid histopathological imaging of skin and breast cancer surgical specimens using immersion microscopy with ultraviolet surface excitation by Quintana, Liza M., Vardeh, Hilde, Faulkner-Jones, Beverly E., Connolly, James L., Do, Daihung, Yoshitake, Tadayuki, Giacomelli, Michael, Cahill, Lucas Christopher, Fujimoto, James G

    Published 2018
    “…Histologic features of specimens using MUSE, nonlinear microscopy (NLM) and conventional hematoxylin and eosin (H & E) histology were evaluated by pathologists to assess potential application in Mohs surgery for skin cancer and lumpectomy for breast cancer. MUSE images of basal cell carcinoma showed high correspondence with frozen section H & E histology, suggesting that MUSE may be applicable to Mohs surgery. …”
    Get full text
    Get full text
    Get full text
    Get full text
    Get full text
    Article
  4. 364

    Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator by Andrew R. Barsky, MD, Fionnbarr O'Grady, PhD, Christopher Kennedy, PhD, Neil K. Taunk, MD, MS, Lei Dong, PhD, James M. Metz, MD, Taoran Li, PhD, Gary M. Freedman, MD

    Published 2019-10-01
    “…All patients underwent lumpectomy (92%) or mastectomy (8%). Tumors were left sided in 44% and bilateral in 9%, and 9% included comprehensive nodal radiation therapy. …”
    Get full text
    Article
  5. 365

    Interactive multidisciplinary pilot workshop to improve medical student perception of and interest in breast surgical oncology by Amani Raheel, Shreeya Dalla, Jalee Birney, Allison M. Aripoli, Meredith Collins, Kelsey E. Larson, Jamie L. Wagner, Christa R. Balanoff, Jordan Baker, Lynn Chollet-Hinton, Lyndsey J. Kilgore

    Published 2024-04-01
    “…BR presented students screening and diagnostic breast imaging followed by hands-on ultrasound-guided biopsy on phantom simulators. BSO demonstrated lumpectomy, mastectomy, sentinel lymph node biopsy, and axillary lymph node dissections while B-PRS demonstrated oncoplastic techniques and autologous flap reconstruction with cadavers. …”
    Get full text
    Article
  6. 366

    MRI Features of Synchronous Masses in Known Breast Cancer Patients in Predicting Benign Versus Malignant Lesions: A Case Based Review at Tertiary Care Cancer Hospital by Sara Rehman, Bushra Rehman, Anis ur Rehman, Islah Ud Din, Aamer Iftikhar, Ainy Javaid, Muhammad Asad Parvaiz

    Published 2023-01-01
    “…Based on these findings, modified radical mastectomy (MRM)/mastectomy was done for 42 patients, 5 patients underwent lumpectomy limited to a single tumor, extended resection done for 14 patients, 5 underwent bilateral breast conservation surgery (BCS), BCS for contralateral breast done for 4 patients undergoing ipsilateral MRM/mastectomy, and bilateral MRM/mastectomies were performed for 2 patients. …”
    Get full text
    Article
  7. 367
  8. 368
  9. 369

    10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event by Jean-Michel Hannoun-Levi, Jocelyn Gal, Renaud Schiappa, Marie-Eve Chand

    Published 2023-01-01
    “…Materials/methods: In this retrospective observational study (N°F20210402152843), patients with 2ndIBTE underwent 2ndCT (lumpectomy + tumor bed re-irradiation). 3rdIBTE (3rdIBTE-FS), regional relapse- (RRFS) and metastatic disease- (MD-FS) free survivals as well as disease-free (DFS), specific (SS) and overall (OS) survival were analyzed. …”
    Get full text
    Article
  10. 370

    Pushing the boundaries. Concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy: A case report by LeJeune Charlotte, Dierickx Daan, Wildiers Hans, Lannoo Lore, Van Calsteren Kristel, Vandecaveye Vincent, Menten Björn, Vermeesch Joris, Amant Frédéric

    Published 2022-02-01
    “…Motivated modifications of breast cancer treatment (mastectomy instead of lumpectomy, AVBD instead of epirubicin-cyclophosphamide chemotherapy), allowed treatment of both cancers during pregnancy. …”
    Get full text
    Article
  11. 371

    Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma by Ritusha Mishra, Rohini Khurana, Himanshu Mishra, Madhup Rastogi, Rahat Hadi

    Published 2016-08-01
    “…Introduction: The conventional dose fractionation of adjuvant radiotherapy (RT) to whole breast is 45–50 Gy in 25 fractions as 1.8–2.0-Gy per fraction. Lumpectomy cavity with a 1.5–2-cm margin receieves additional 10- 16 Gy doseas boost. …”
    Get full text
    Article
  12. 372
  13. 373

    A Prognostic Model Based on Nutritional Risk Index in Operative Breast Cancer by Fei Lin, Wen Xia, Miao Chen, Tongchao Jiang, Jia Guo, Yi Ouyang, Haohui Sun, Xiaoyu Chen, Wuguo Deng, Ling Guo, Huanxin Lin

    Published 2022-09-01
    “…Methods: We retrospectively enrolled 1347 breast cancer patients who underwent mastectomy or lumpectomy between January 2011 and November 2012. Using a cutoff value of 110.59, patients were divided into a high-NRI group and a low-NRI group. …”
    Get full text
    Article
  14. 374

    Exploring Surgeons’, Nurses’, and Patients’ Information Seeking Behavior on Medical Innovations by Stephen Whyte, PhD, Laura Bray, PhD, Ho Fai Chan, PhD, Raymond J. Chan, PhD, Jeremy Hunt, MBBS, FRACS, Tim S. Peltz, PhD, MBBS, Uwe Dulleck, PhD, Dietmar W. Hutmacher, PhD

    Published 2022-06-01
    “…Women who underwent a type of mastectomy procedure (compared with lumpectomy patients) were more likely to choose a former patient than a surgeon for seeking information relating to a new breast implant technology. …”
    Get full text
    Article
  15. 375
  16. 376

    Can Pre-biopsy Second-Look Breast Ultrasound Affect Clinical Management? Experience From a Single Tertiary Hospital by Li Ma, Jing Qin, Lingyan Kong, Jialin Zhao, Mengsu Xiao, Hongyan Wang, Jing Zhang, Yuxin Jiang, Jianchu Li, He Liu, Qingli Zhu

    Published 2022-05-01
    “…Interpretation changes in terms of biopsy recommendation and surgical management (i.e., lumpectomy to mastectomy) were analyzed.ResultsA total of 537 patients were enrolled in this study. …”
    Get full text
    Article
  17. 377

    Differences in Time Burden across Local Therapy Strategies for Early-stage Breast Cancer by Cameron W. Swanick, MD, Jing Jiang, PhD, J. Alberto Maldonado, BA, Xiudong Lei, PhD, Ya-Chen Tina Shih, PhD, Abigail S. Caudle, MD, MS, Donald P. Baumann, MD, Sharon H. Giordano, MD, MPH, Simona F. Shaitelman, MD, EdM, Shervin M. Shirvani, MD, MPH, Benjamin D. Smith, MD

    Published 2021-11-01
    “…We compared the time burden for three common local therapies for breast cancer: (1) lumpectomy plus whole-breast irradiation (Lump+WBI), (2) mastectomy without radiation or reconstruction (Mast alone), and (3) mastectomy without radiation but with reconstruction (Mast+Recon). …”
    Get full text
    Article
  18. 378

    Assessing the Impact of CALGB 9343 on Surgical Trends in Elderly-Women With Stage I ER+ Breast Cancer: A SEER-Based Analysis by Jose G. Bazan, James L. Fisher, Ko Un Park, Elizabeth A. Marcus, Marisa A. Bittoni, Julia R. White

    Published 2019-07-01
    “…Purpose: Lumpectomy (L) and breast radiotherapy (RT) results in equivalent outcomes in comparison to mastectomy (M) for early-stage breast cancer (BC) based on randomized controlled trials (RCT). …”
    Get full text
    Article
  19. 379

    Outcomes in Hybrid Breast Reconstruction: A Systematic Review by Mario Alessandri Bonetti, Riccardo Carbonaro, Francesco Borelli, Francesco Amendola, Giuseppe Cottone, Luca Mazzocconi, Alessandro Mastroiacovo, Nicola Zingaretti, Pier Camillo Parodi, Luca Vaienti

    Published 2022-09-01
    “…We included a total of 753 breast reconstructions in 585 patients undergoing mastectomy or demolitive breast surgeries other than mastectomy (quadrantectomy, segmentectomy, or lumpectomy) due to breast cancer or genetic predisposition to breast cancer. …”
    Get full text
    Article
  20. 380

    Dysregulation of metabolic‐associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin‐15 targeting fatigue by Joseph Bohlen, Sarah L. McLaughlin, Hannah Hazard‐Jenkins, Aniello M. Infante, Cortney Montgomery, Mary Davis, Emidio E. Pistilli

    Published 2018-08-01
    “…Methods Early stage non‐metastatic female breast cancer patients (n = 14) and female non‐cancer patients (n = 6) provided a muscle biopsy of the pectoralis major muscle during mastectomy, lumpectomy, or breast reconstruction surgeries. The breast cancer patients were diagnosed with either luminal (ER+/PR+, n = 6), triple positive (ER+/PR+/Her2/neu+, n = 5), or triple negative (ER−/PR−/Her2/neu−, n = 3) breast tumours and were being treated with curative intent either with neoadjuvant chemotherapy followed by surgery or surgery followed by standard post‐operative therapy. …”
    Get full text
    Article